ANDREW GEPHARDT: Open Payments
NPI 1881303824 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$551 in 26 payments from 10 companies in 2025. Trend: 2023 $480 · 2024 $521 · 2025 $551
Food & beverage: $551
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $128 |
| Axsome Therapeutics, Inc. | 4 | $77 |
| ABBVIE INC. | 4 | $70 |
| Forte Bio-Pharma LLC | 3 | $64 |
| Lundbeck LLC | 2 | $58 |
| Collegium Pharmaceutical, Inc. | 3 | $53 |
| Boston Scientific Corporation | 2 | $32 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Curonix LLC | 1 | $22 |
Products named: NURTEC ODT, Symbravo, PROLATE, VYEPTI, QULIPTA, UBRELVY, Nucynta, JOURNAVX.
Industry payments across NV — which companies pay providers there.
